{
  "id": 9375719,
  "title": "Why Fleury is up 50% this year? BTG has a hypothesis",
  "url": "https://urgent.news/2026/09/23/por-que-o-fleury-sobe-50-este-ano-o-btg-tem-uma-hipotese",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-23T16:44:51.000Z",
  "source": {
    "name": "Brazil Journal",
    "slug": "brazil-journal",
    "url": "https://braziljournal.com/por-que-o-fleury-sobe-50-este-ano-o-btg-tem-uma-hipotese/"
  },
  "original_language": "pt",
  "account": "The Fleury company's stock has risen almost 50% since the beginning of the year, outpacing the Ibovespa index and other healthcare companies. According to a report by BTG Pactual, this surge is largely due to an expansion of multiples, rather than a revision of earnings. The bank's analyst, Samuel Alves, notes that the company's performance is linked to a global trend of re-rating diagnostic companies, driven by growth in preventive medicine and a shift towards more proactive healthcare. BTG maintained its neutral recommendation for Fleury, preferring Rede D'Or in the healthcare sector, and valued Fleury at R$ 12 billion.",
  "summary": "A ação do Fleury subiu quase 50% desde o início do ano, 3x a valorização do Ibovespa e acima de outras empresas do setor de saúde – levando muitos investidores a questionar o motivo da disparada. O BTG Pactual se debruçou sobre o tema e chegou a duas conclusões: a maior parte da valorização veio […] The post Por que o Fleury sobe 50% este ano? O BTG tem uma hipótese appeared first on Brazil…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}